Authors' Reply

Murray J Cuckle H Taylor G Hewison J . Screening for fragile X syndrome: information needs for health planners. J Med Screen 1997; 4: 60–94.

Meagher S Davison G . Early second trimester determination of fetal gender by ultrasound. Ultrasound Obstet Gynecol 1996; 8: 322–4.

Lo YMD Corbetta N Chamberlain PF . Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485–7.

Taylor AK Safanda JF Fall MZ . Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 1994; 271: 507–14.

Reiss AL Freund L Abrams MT Boehm C Kazaxian H . Neurobehavioural effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet 1993; 52: 884–94.

Thompson NM Gulley ML Rogeness GA . Neurobehavioral characteristics of CGG amplification status in fragile X females. Am J Med Genet 1994; 54: 378–83.

Sobesky WE Pennington BF Porter D Hull CE Hagerman RJ . Emotional and neurocognitive deficits in fragile X. Am J Med Genet 1994; 51: 378–85.

Mazzocco MM Hagerman RJ Pennington BF . Problem solving limitations among cytogenetically expressing fragile X women. Am J Med Genet 1992; 43: 78–86.

Mazzocco MM Pennington BF Hagerman RJ . The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr 1993; 14: 328–35.